TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: reduced negative emotional reaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced perceived social isolation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Clinical Effectiveness (CE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discomfort rate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plasma clearance of S-mephenytoin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion of 4'-hydroxymephenytoin metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical shortening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Physical disability questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee pain questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in general parenting
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in 8 ox-NEFA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dynamic analgesia during physical functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restriction by pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recovery of physical independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Infections prevented
Endpoint domain: Adverse events/effects
Primary endpoint: Relative hazard of treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Area under the plasma concentration-time curve of glimepiride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration of glimepiride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life of glimepiride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multifidus atrophy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lumbar lordosis restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: postoperative VAS for back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol use disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of tourniquet inflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving PASI 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving PGA of cleared or minimal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median DLQI changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time to peak clot formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: length of use of 5-ml bottle
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean cobalt ion level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate to severe pseudotumour
Endpoint domain: Adverse events/effects
Primary endpoint: 1-week mortality
Endpoint domain: Mortality/survival
Primary endpoint: perceived general health of the patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived burden on the informal caregiver
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: satisfaction with the delivered care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IL-6 levels in monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CBir1-specific peripheral T-cell proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IFN-gamma(+) cells in lamina propria mononuclear cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean steady-state trough plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy assessed by ACR responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total plasma glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: insulin clearance reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: freedom from biochemical or clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingivitis development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS‐II scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ulcer scarring rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Expectations of increased duration of symptoms of generalized anxiety disorder
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MSNA (muscle sympathetic nerve activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of patients showing successful treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lipid peroxide concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Karyotypic differentiation of water buffaloes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haplotype diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sequence diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High serum IgA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: total sleep time (sTST)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: time‐to‐sleep onset (sTSO)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: number of awakenings (sNAW)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: transient ischemic attack/stroke
Endpoint domain: Mortality/survival
Primary endpoint: HbA1c change from baseline to week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in mean MWT sleep latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final ESS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of WFDRI in detecting treatment-requiring ROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmological outcomes
Primary endpoint: Specificity of WFDRI in detecting treatment-requiring ROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmological outcomes
Primary endpoint: Perceptions of leg tiredness and soreness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Median haemoglobin concentration in salvaged blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lipid excretion into feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholesterol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TEG variable reaction time (R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: General psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of urothelial carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Risk of squamous cell carcinoma (SCC)
Endpoint domain: Mortality/survival
Primary endpoint: numbers of infectious events
Endpoint domain: Adverse events/effects
Primary endpoint: Intracoronary concentrations of TNF‐a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intracoronary concentrations of IL‐6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibiotic-related length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: resolution of postoperative ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: return to a regular diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: length of postoperative stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variability in PICU length of stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC subscore A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief assessed with VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: full-scale IQ scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Infected pancreatic necrosis and abscesses
Endpoint domain: Adverse events/effects
Primary endpoint: lower limb discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leg heaviness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE rates at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Mean relative bioavailability for inhaled GH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative biopotency based on IGF-I response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Well tolerated inhaled GH
Endpoint domain: Adverse events/effects
Primary endpoint: mean change of the calcium score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean time to sheath removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of interns with in-person interactions greater than 50% of the time
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percentage of interns receiving teaching in more than 50% of interactions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Spinal mobility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of hospitalization
Endpoint domain: Resource use
Primary endpoint: Success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Diabetes awareness and knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge levels about malaria
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PrEP compliance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DVAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: levels of burnout
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: self‐rated stress behavior
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: obsessive‐compulsive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in serum lipid subclasses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood-aqueous barrier damage (BAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Small bowel transit acceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: average number of relevant references retrieved per search
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GIR profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Control of systemic arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of myocardial cell damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Menstrual scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean FLACC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to full skin epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deltaVO(2)/deltaW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of OAB-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOBID-2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADL function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Development of migraine (MO)
Endpoint domain: Mortality/survival
Primary endpoint: Mental component summary (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vertical Jump (VJ) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentric peak torque during knee extension and flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean per-patient savings in direct medical costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in hospital days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PGA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSA involvement improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA×BSA measure improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diurnal slumber
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Contraceptive reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement for renal artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Sensitivity for aneurysm extent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Sensitivity for perianeurysmal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Positive agreement of InflammaDry test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative agreement of InflammaDry test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in global anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fasting glucose serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemoglobin response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Subjective outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant tobacco smoke exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal smoking postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total home and car smoking ban
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fatal/nonfatal stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Headache pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of bone metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: temporary ipsilateral vocal cord motility dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of bar-clip dentures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retreatment rate of ball attachment IODs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful desensitization (passing DBPCFC without symptoms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Baseline levels of IgE against peanut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Baseline levels of IgE against Ara h 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Baseline levels of IgE against Ara h 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of responders in treatment group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lobar volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of withdrawal movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of withdrawal movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of clinically significant apnea, bradycardia, or desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in melasma area and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: motor power of wrist extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: spasticity of elbow flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: pain freedom at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS score of 30 or lower
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infusion temperature change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete eradication of esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time (extubation and eye opening times)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation due to failed rescue
Endpoint domain: Adverse events/effects
Primary endpoint: Dosage of heparin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dosage of protamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endline test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of paracetamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success in quitting smoking
Endpoint domain: Mortality/survival
Primary endpoint: Mean distance of the cup below the anterosuperior acetabular rim
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of cups with anterior overhang
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propensity to potential psoas impingement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midcycle endometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of KMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratings of perceived exertion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Positive feelings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PFP recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean VAS scores for dentin hypersensitivity (DH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory depression (SpO2 < 90%)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in photodamaged skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gain in visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in retinal nerve fibre layer (RNFL) thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in ganglion cell layer (GCL) thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute N160 latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IHTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: laterality of information transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: video enterorrhaphy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes